Your browser doesn't support javascript.
loading
Worldwide Network for Blood and Marrow Transplantation (WBMT) recommendations for establishing a hematopoietic stem cell transplantation program in countries with limited resources (Part II): Clinical, technical and socio-economic considerations.
Aljurf, M; Weisdorf, D; Hashmi, S K; Nassar, A; Gluckman, E; Mohty, M; Rizzo, D; Pasquini, M; Hamadani, M; Saber, W; Hari, P; Kharfan-Dabaja, M; Majhail, N; Gerges, U; Hamidieh, Amir Ali; Hussain, F; Elhaddad, A; Mahmoud, H K; Tbakhi, A; Othman, T B; Hamladji, R M; Bekadja, M A; Ahmed, P; Bazarbachi, A; Adil, S; Alkindi, S; Ladeb, S; Dennison, D; Patel, M; Lu, P; Quessar, A E; Okamoto, S; Atsuta, Y; Alhejazi, A; Ayas, M; Ahmed, S O; Novitzky, N; Srivastava, A; Seber, A; Elsolh, H; Ghavamzadeh, A; Confer, D; Kodera, Y; Greinix, H; Szer, J; Horowitz, M; Niederwieser, D.
Afiliação
  • Aljurf M; Hematology Department, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia. Electronic address: maljurf@kfshrc.edu.sa.
  • Weisdorf D; University of Minnesota, Minneapolis, MN, USA.
  • Hashmi SK; Hematology Department, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia; Department of Medicine, Mayo Clinic, Rochester, MN, USA.
  • Nassar A; National Cancer Institute, Cairo University, Cairo, Egypt.
  • Gluckman E; Eurocord Hôpital Saint-Louis and University Paris Diderot, Paris, France.
  • Mohty M; Hopital Saint-Antoine, Sorbonne University, Paris, France.
  • Rizzo D; Center for International Blood and Marrow Transplant Research (CIBMTR), Milwaukee, WI, USA.
  • Pasquini M; Center for International Blood and Marrow Transplant Research (CIBMTR), Milwaukee, WI, USA.
  • Hamadani M; Center for International Blood and Marrow Transplant Research (CIBMTR), Milwaukee, WI, USA.
  • Saber W; Center for International Blood and Marrow Transplant Research (CIBMTR), Milwaukee, WI, USA.
  • Hari P; Center for International Blood and Marrow Transplant Research (CIBMTR), Milwaukee, WI, USA.
  • Kharfan-Dabaja M; Department of Medicine, Division of Hematology-Oncology and Blood and Marrow Transplantation Program, Mayo Clinic, Jacksonville, FL, USA.
  • Majhail N; Blood and Marrow Transplant Program, Cleveland Clinic, Cleveland, OH, USA.
  • Gerges U; Hematologic Malignancies & Bone Marrow Transplant, Department of Medicial Oncology, New York-Presbyterian Hospital/Weill Cornell Medical Center, New York, USA.
  • Hamidieh AA; Tehran University of Medical Sciences, Hematology, Oncology & SCT Research Ctr., Tehran, Iran.
  • Hussain F; Hematology Department, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia.
  • Elhaddad A; National Cancer Institute, Cairo University, Cairo, Egypt.
  • Mahmoud HK; National Cancer Institute, Cairo University, Cairo, Egypt.
  • Tbakhi A; King Hussein Cancer Center, Amman, Jordan.
  • Othman TB; Center National de Greffe de Moelle Osseuse de Tunis, Tunis, Tunisia.
  • Hamladji RM; Pierre and Marie Curie Center, Algiers, Algeria.
  • Bekadja MA; University Hospital Establishment 1st Nov, Oran, Algeria.
  • Ahmed P; Armed Forces Institute of Transplantation, Rawalpindi, Pakistan.
  • Bazarbachi A; Hematology/Oncology, American University of Beirut Medical Center, Beirut, Lebanon.
  • Adil S; Aga Khan University Hospital, Karachi, Pakistan.
  • Alkindi S; Sultan Qaboos University Hospital, Muscat, Oman.
  • Ladeb S; Center National de Greffe de Moelle Osseuse de Tunis, Tunis, Tunisia.
  • Dennison D; Sultan Qaboos University Hospital, Muscat, Oman.
  • Patel M; University of the Witwatersrand, Johannesburg, South Africa.
  • Lu P; Hebei Yanda Ludaopei Hospital, Langfang, China.
  • Quessar AE; Hôpital 20 Août, Casablanca, Morocco.
  • Okamoto S; Japanese Data Center for Hematopoietic Cell Transplantation, Nagoya, Japan.
  • Atsuta Y; Keio University School of Medicine, Tokyo, Japan.
  • Alhejazi A; King Abdulaziz Medical City, NGHA, Riyadh, Saudi Arabia.
  • Ayas M; Hematology Department, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia.
  • Ahmed SO; Hematology Department, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia.
  • Novitzky N; African Blood & Marrow Transplantation Society (AFBMT), South Africa.
  • Srivastava A; Christian Medical College & Hospital, Bagayam, Vellore, India.
  • Seber A; Instituto de Oncologia Pediatrica, Sao Paulo, Brazil.
  • Elsolh H; Hematology Department, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia.
  • Ghavamzadeh A; Tehran University of Medical Sciences, Hematology, Oncology & SCT Research Ctr., Tehran, Iran.
  • Confer D; Center for International Blood and Marrow Transplant Research (CIBMTR), Milwaukee, WI, USA.
  • Kodera Y; Center for Hematopoietic Stem Cell Transplantation, Aichi Medical University Hospital, Nagakute, Japan.
  • Greinix H; Medical University of Graz, LKH-Univ. Klinikum Graz, Austria.
  • Szer J; Department of Clinical Haematology, Royal Melbourne Hospital, VIC 3050, Australia.
  • Horowitz M; Center for International Blood and Marrow Transplant Research (CIBMTR), Milwaukee, WI, USA.
  • Niederwieser D; Center for Hematopoietic Stem Cell Transplantation, Aichi Medical University Hospital, Nagakute, Japan; Department of Hematology and Medical Oncology, University Hospital, Leipzig, Germany.
Hematol Oncol Stem Cell Ther ; 13(1): 7-16, 2020 03.
Article em En | MEDLINE | ID: mdl-31449781
ABSTRACT
The development of hematopoietic stem cell transplantation (HSCT) programs can face significant challenges in most developing countries because such endeavors must compete with other government health care priorities, including the delivery of basic services. While this is may be a limiting factor, these countries should prioritize development of the needed expertise to offer state of the art treatments including transplantation, by providing financial, technological, legal, ethical and other needed support. This would prove beneficial in providing successful programs customized to the needs of their population, and potentially provide long-term cost-savings by circumventing the need for their citizens to seek care abroad. Costs of establishing HSCT program and the costs of the HSCT procedure itself can be substantial barriers in developing countries. Additionally, socioeconomic factors intrinsic to specific countries can influence access to HSCT, patient eligibility for HSCT and timely utilization of HSCT center capabilities. This report describes recommendations from the Worldwide Network for Blood and Marrow Transplantation (WBMT) for establishing HSCT programs with a specific focus on developing countries, and identifies challenges and opportunities for providing this specialized procedure in the resource constrained setting.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transplante de Medula Óssea / Transplante de Células-Tronco Hematopoéticas / Condicionamento Pré-Transplante / Países em Desenvolvimento Tipo de estudo: Clinical_trials / Guideline / Health_economic_evaluation / Prognostic_studies Limite: Humans Idioma: En Revista: Hematol Oncol Stem Cell Ther Assunto da revista: HEMATOLOGIA / NEOPLASIAS Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transplante de Medula Óssea / Transplante de Células-Tronco Hematopoéticas / Condicionamento Pré-Transplante / Países em Desenvolvimento Tipo de estudo: Clinical_trials / Guideline / Health_economic_evaluation / Prognostic_studies Limite: Humans Idioma: En Revista: Hematol Oncol Stem Cell Ther Assunto da revista: HEMATOLOGIA / NEOPLASIAS Ano de publicação: 2020 Tipo de documento: Article